- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04477720
Retrospective Analysis of De-identified Deceased HCC Patients
July 25, 2023 updated by: Carr, Brian
HCC Observation Study
De-identified deceased HCC patients who were not surgical candidates were evaluated for their clinical baseline characteristics associated with their survival.
Baselines included tumor markers, blood counts and liver function tests and CAT-scan based tumor size and numbers and presence of portal vein thrombosis.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
1000
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients presenting for HCC management
Description
Inclusion Criteria:
- biopsy-proven HCC
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Survival
Time Frame: 10 years
|
Overall survival
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 1995
Primary Completion (Actual)
May 1, 2009
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
July 16, 2020
First Submitted That Met QC Criteria
July 16, 2020
First Posted (Actual)
July 20, 2020
Study Record Updates
Last Update Posted (Actual)
July 27, 2023
Last Update Submitted That Met QC Criteria
July 25, 2023
Last Verified
July 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- BCarr
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Survival
-
Peking University First HospitalCompletedOverall SurvivalChina
-
Columbia UniversityBill and Melinda Gates Foundation; United NationsCompletedChild SurvivalEthiopia, Ghana, Kenya, Malawi, Mali, Nigeria, Rwanda, Senegal, Tanzania, Uganda
-
University of SienaCompletedRestoration Survival
-
Metabolic Technologies Inc.Koach Sport and NutritionCompletedSurvival TrainingIsrael
-
ChimerixTerminated
-
Universitair Ziekenhuis BrusselCompletedSurvival | Embryo QualityBelgium
-
Technical University of MunichUnknown
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
University Medical Center GroningenCompletedSurvival | Immediate Dentin Sealing
-
Peking Union Medical College HospitalOrigiMedRecruitingQuality of Life | Objective Response Rate | Overall Survival | Progression-free Survival | Disease Control Rate | Duration of Response | Five-year Survival RateChina